Considering its increased levels correlating with glioma grade and malignancy and given its broad expression pattern within the TME, we considered CD44 to be an interesting target to investigate in the context of tumor-host interactions affecting glioma invasion. The gene discussed is CD44; the disease is central nervous system cancer.